Complejo asistencial universitario de Leon

León 24080

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, HER2 Positive Breast Cancer, Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC), Marginal Zone Lymphoma, Multiple Myeloma, Non Alcoholic Steatohepatitis (NASH), Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage IIIB, Nonsmall Cell Lung Cancer, Stage IV, Relapsed/Refractory Follicular Lymphoma, Urothelial Carcinoma

Studies at this site

• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer — Completed
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants — Stopped early
• Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed